In ₹ Crore except Per Share 12 Months Ending | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|
| Other Income | — | — | — | 470.3 | |
| Revenue Detail — as filed | |||||
| + Operating Income | — | — | — | 10,377.1 | |
| + Income from Investments (net) | — | — | — | 1,350.5 | |
| Expense Detail — as filed | |||||
| + Employee Remuneration & Welfare | — | — | — | 377.4 | |
| + Commission (net) | — | — | — | 2,387.3 | |
| + Commission & Brokerage (net) | — | — | — | 2,387.3 | |
| + Non-operating Expense | — | — | — | 571.9 | |
| + Non-operating Provision — Doubtful Debts | — | — | — | 12.0 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | |||||
| Profit before Extraordinary Items | — | — | — | 586.5 | |
| Profit / (Loss) before Tax — alt tag | — | — | — | 586.5 | |
| + Provision for Tax | — | — | — | 94.1 | |
| Profit / (Loss) after Tax | — | — | — | 492.4 | |
| Profit Carried to Balance Sheet | — | — | — | 492.4 | |
| Per Share — as-filed variants | |||||
| Basic & Diluted EPS before Extraordinary (not annualised) | — | — | — | 5.33 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | — | — | — | 5.31 | |
| Appropriations & Transfers | |||||
| + Transfer to Profit & Loss Account | — | — | — | 866.9 | |
| Reserves & Surplus excl. Revaluation Reserve | — | — | — | 14,494.0 | |
| Insurance — Revenue Account (Policyholders') | |||||
| Premium Earned | — | — | — | 8,556.3 | |
| + Gross Premiums Written | — | — | — | 11,043.2 | |
| + Net Premium Written | — | — | — | 8,464.9 | |
| + Operating Expenses — Insurance Business | — | — | — | 829.4 | |
| + Non-operating Expenses — Non-insurance | — | — | — | 559.9 | |
| + Claims Paid | — | — | — | 4,631.2 | |
| + Incurred Claims | — | — | — | 6,293.6 | |
| + Change in Outstanding Claims | — | — | — | 1,662.4 | |
| Insurance — Shareholders' Account | |||||
| + Income — Shareholders' Account | — | — | — | 1,158.4 | |
| + Shareholders' Investment Income | — | — | — | 289.5 | |
| + Transfer from Policyholders' Fund | — | — | — | 866.9 | |
| With Unrealised Gains | — | — | — | 0.1 | |
| Without Unrealised Gains | — | — | — | 0.1 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | |||||
| Solvency Ratio | — | — | — | 2.49 | |
| Combined Ratio | — | — | — | 4.46 | |
| Incurred Claim Ratio | — | — | — | 2.94 | |
| Net Retention Ratio | — | — | — | 3.07 | |
| Expenses of Management Ratio | — | — | — | 1.66 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||
| Investor Complaints — Received | — | — | — | 1.00 | |
| Investor Complaints — Disposed | — | — | — | 1.00 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||
| Operating Expenses | — | — | — | 9,510.2 | |
| Other Operating Expenses | — | — | — | 451.9 | |